Expression of the beta-amyloid transporter, LRP-1, in aging choroid plexus: implications for the CSF-brain system in NPH and Alzheimer's disease by Johanson, Conrad et al.
BioMed  Central
Page 1 of 2
(page number not for citation purposes)
Cerebrospinal Fluid Research
Open Access Oral presentation
Expression of the beta-amyloid transporter, LRP-1, in aging choroid 
plexus: implications for the CSF-brain system in NPH and 
Alzheimer's disease
Conrad Johanson*, Stephanie Flaherty, Arthur Messier, John Duncan III and 
Gerald Silverberg
Address: Dept. of Clinical Neurosciences, Brown Medical School, Providence, RI 02903 USA
Email: Conrad Johanson* - Conrad_Johanson@Brown.edu
* Corresponding author    
Background
The CSF system, including the choroid plexus, is an
important route for removing the A-Beta peptides that, in
high concentrations, injure neurons. Central retention of
A-Beta peptides occurs when the blood-CSF and blood-
brain barriers suffer deficits in aging and disease. LRP-1, a
transporter, which actively removes A-Beta from extracel-
lular fluid, undergoes expression changes in senescence,
which is a risk factor for NPH and AD. We hypothesize
that LRP-1 activity in the 'barriers' is essential for the well-
being of the brain's interstitial and cerebrospinal fluids.
This study has assessed the expression of LRP-1 in the
choroid plexus and cerebral capillaries of aging rats in
order to elucidate the state of this A-Beta clearance trans-
porter in senescence. Faulty A-Beta disposal from the CNS
may predispose to NPH and the reduced CSF turnover rate
in AD.
Materials and methods
Lateral ventricle choroid plexus and cortical capillaries,
for comparison, were assessed for LRP-1 expression by
immunohistochemistry (IHC) and RT-PCR. Tissue speci-
mens were taken from Brown-Norway/Fischer (B-N/F)
rats at various ages from 3 to >30 mo. It was of interest to
compare the time course of LRP-1 expression in the
blood-CSF vs. the blood-brain barrier to obtain informa-
tion about the relative abilities of these major transport
interfaces to clear A-Beta from the CNS in young vs. senes-
cent adults.
Results
LRP-1 by IHC assessment was expressed extensively in the
choroid plexus epithelium of healthy young adults;
expression of this A-Beta transporter was sustained even in
the oldest animals. This was confirmed by RT-PCR, which
showed mRNA for LRP-1 in the choroidal epithelium at
all ages, with enhancement of the transcript in the oldest
B-N/F animals. In contrast, LRP-1 expression in cerebral
microvessels declined throughout aging, and was virtually
not present at 12 mo. The IHC findings for LRP-1 in brain
capillaries at various ages were in agreement with the cor-
responding PCR data.
Conclusion
Our findings demonstrate that the LRP-1 'barrier trans-
porter system' that removes the potentially harmful A-
Beta from the CNS undergoes a different time course in
expression (choroid plexus vs. cortical capillaries) as
adulthood progresses into senescent debilitation. In early
adult life, the BBB may have the prominent role in pro-
tecting the brain from excessive A-Beta buildup. However,
with advanced aging, the neurons may become progres-
sively more dependent upon the choroid plexus-CSF sys-
tem for maintaining A-Beta homeostasis in the
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extracellular fluid of the CNS. Stabilizing (or even aug-
menting) the capacity of the LRP-1 transporters in the
'barriers' may be significant in slowing down the onset of
NPH and/or the more severe stages of CSF-brain disrup-
tion in AD. Supported by the Rae Richter, Saunders and
Brown Neurosurgery Foundations.